# Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy

> **NCT07706088** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 40 (estimated)

## Conditions studied

- Neuropathy, Small Fiber
- Diabete Mellitus

## Interventions

- **DRUG:** Tirzepatide 2.5mg weekly
- **DRUG:** all standard of care to diabetic patient besides tirzepatide

## Key facts

- **NCT ID:** NCT07706088
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706088, "Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07706088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*